Which has higher earnings & valuation, PACS or GH?

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.29B 1.34 $191.54M $1.56 28.70 Guardant Health $982.02M 19.99 -$416.28M -$3.39 N/A

Does the media prefer PACS or GH?

In the previous week, Guardant Health had 8 more articles in the media than PACS Group. MarketBeat recorded 11 mentions for Guardant Health and 3 mentions for PACS Group. Guardant Health's average media sentiment score of 1.04 beat PACS Group's score of 0.39 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Guardant Health 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer PACS or BTSG?

In the previous week, BrightSpring Health Services had 5 more articles in the media than PACS Group. MarketBeat recorded 8 mentions for BrightSpring Health Services and 3 mentions for PACS Group. BrightSpring Health Services' average media sentiment score of 0.96 beat PACS Group's score of 0.39 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BrightSpring Health Services 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PACS or FMS?

In the previous week, PACS Group had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 3 mentions for PACS Group and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.05 beat PACS Group's score of 0.39 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, HIMS or PACS?

PACS Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hims & Hers Health $2.35B 3.22 $128.37M -$0.09 N/A PACS Group $5.29B 1.34 $191.54M $1.56 28.70

Does the media favor HIMS or PACS?

In the previous week, Hims & Hers Health had 4 more articles in the media than PACS Group. MarketBeat recorded 7 mentions for Hims & Hers Health and 3 mentions for PACS Group. Hims & Hers Health's average media sentiment score of 0.68 beat PACS Group's score of 0.39 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, BLLN or PACS?

PACS Group has higher revenue and earnings than Billiontoone. PACS Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $354.54M 16.23 $7.45M $0.55 227.53 PACS Group $5.29B 1.34 $191.54M $1.56 28.70

Does the media prefer BLLN or PACS?

In the previous week, Billiontoone and Billiontoone both had 3 articles in the media. Billiontoone's average media sentiment score of 0.57 beat PACS Group's score of 0.39 indicating that Billiontoone is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

PACS Group (PACS) Competitors

$44.77 -1.36 (-2.95%)

Closing price 07/20/2026 03:59 PM Eastern

Extended Trading

$45.07 +0.30 (+0.67%)

As of 09:15 AM Eastern

Compare

PACS vs. GH, BTSG, FMS, HIMS, and BLLN

Should you buy PACS Group stock or one of its competitors? MarketBeat compares PACS Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with PACS Group include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), and Billiontoone (BLLN). These companies are all part of the "healthcare" industry.

How does PACS Group compare to Guardant Health?

PACS Group (NYSE:PACS) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

PACS Group has a net margin of 4.49% compared to Guardant Health's net margin of -40.10%. PACS Group's return on equity of 26.47% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Guardant Health	-40.10%	N/A	-26.42%

In the previous week, Guardant Health had 8 more articles in the media than PACS Group. MarketBeat recorded 11 mentions for Guardant Health and 3 mentions for PACS Group. Guardant Health's average media sentiment score of 1.04 beat PACS Group's score of 0.39 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardant Health	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.34	$191.54M	$1.56	28.70
Guardant Health	$982.02M	19.99	-$416.28M	-$3.39	N/A

92.6% of Guardant Health shares are owned by institutional investors. 70.1% of PACS Group shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

PACS Group currently has a consensus target price of $50.60, suggesting a potential upside of 13.02%. Guardant Health has a consensus target price of $160.04, suggesting a potential upside of 8.09%. Given PACS Group's higher possible upside, equities research analysts clearly believe PACS Group is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96

PACS Group has a beta of -0.08, indicating that its share price is 108% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.59, indicating that its share price is 59% more volatile than the broader market.

Summary

PACS Group beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does PACS Group compare to BrightSpring Health Services?

PACS Group (NYSE:PACS) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

In the previous week, BrightSpring Health Services had 5 more articles in the media than PACS Group. MarketBeat recorded 8 mentions for BrightSpring Health Services and 3 mentions for PACS Group. BrightSpring Health Services' average media sentiment score of 0.96 beat PACS Group's score of 0.39 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
BrightSpring Health Services	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PACS Group has a net margin of 4.49% compared to BrightSpring Health Services' net margin of 2.27%. PACS Group's return on equity of 26.47% beat BrightSpring Health Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
BrightSpring Health Services	2.27%	14.63%	4.41%

PACS Group currently has a consensus price target of $50.60, indicating a potential upside of 13.02%. BrightSpring Health Services has a consensus price target of $70.12, indicating a potential downside of 0.54%. Given PACS Group's higher possible upside, equities research analysts plainly believe PACS Group is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
BrightSpring Health Services	0 Sell rating(s)	1 Hold rating(s)	18 Buy rating(s)	1 Strong Buy rating(s)	3.00

PACS Group has a beta of -0.08, suggesting that its share price is 108% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.79, suggesting that its share price is 79% more volatile than the broader market.

PACS Group has higher earnings, but lower revenue than BrightSpring Health Services. PACS Group is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.34	$191.54M	$1.56	28.70
BrightSpring Health Services	$12.91B	1.08	$190.67M	$1.41	50.00

Summary

BrightSpring Health Services beats PACS Group on 9 of the 15 factors compared between the two stocks.

How does PACS Group compare to Fresenius Medical Care AG & Co. KGaA?

PACS Group (NYSE:PACS) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

PACS Group currently has a consensus price target of $50.60, suggesting a potential upside of 13.02%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $28.00, suggesting a potential upside of 16.30%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than PACS Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.34	$191.54M	$1.56	28.70
Fresenius Medical Care AG & Co. KGaA	$19.36B	0.67	$1.11B	$1.90	12.67

In the previous week, PACS Group had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 3 mentions for PACS Group and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.05 beat PACS Group's score of 0.39 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to PACS Group's net margin of 4.49%. PACS Group's return on equity of 26.47% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

PACS Group has a beta of -0.08, indicating that its stock price is 108% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 70.1% of PACS Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

PACS Group and Fresenius Medical Care AG & Co. KGaA tied by winning 8 of the 16 factors compared between the two stocks.

How does PACS Group compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

PACS Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.22	$128.37M	-$0.09	N/A
PACS Group	$5.29B	1.34	$191.54M	$1.56	28.70

Hims & Hers Health has a beta of 2.35, indicating that its stock price is 135% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, indicating that its stock price is 108% less volatile than the broader market.

Hims & Hers Health presently has a consensus target price of $30.70, suggesting a potential downside of 6.08%. PACS Group has a consensus target price of $50.60, suggesting a potential upside of 13.02%. Given PACS Group's stronger consensus rating and higher probable upside, analysts plainly believe PACS Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 70.1% of PACS Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Hims & Hers Health had 4 more articles in the media than PACS Group. MarketBeat recorded 7 mentions for Hims & Hers Health and 3 mentions for PACS Group. Hims & Hers Health's average media sentiment score of 0.68 beat PACS Group's score of 0.39 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has a net margin of 4.49% compared to Hims & Hers Health's net margin of -0.56%. PACS Group's return on equity of 26.47% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
PACS Group	4.49%	26.47%	4.36%

Summary

PACS Group beats Hims & Hers Health on 11 of the 16 factors compared between the two stocks.

How does PACS Group compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and PACS Group (NYSE:PACS) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Billiontoone presently has a consensus target price of $126.00, indicating a potential upside of 0.69%. PACS Group has a consensus target price of $50.60, indicating a potential upside of 13.02%. Given PACS Group's stronger consensus rating and higher probable upside, analysts plainly believe PACS Group is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

PACS Group has higher revenue and earnings than Billiontoone. PACS Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$354.54M	16.23	$7.45M	$0.55	227.53
PACS Group	$5.29B	1.34	$191.54M	$1.56	28.70

In the previous week, Billiontoone and Billiontoone both had 3 articles in the media. Billiontoone's average media sentiment score of 0.57 beat PACS Group's score of 0.39 indicating that Billiontoone is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has a net margin of 4.49% compared to Billiontoone's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
PACS Group	4.49%	26.47%	4.36%

Summary

PACS Group beats Billiontoone on 8 of the 12 factors compared between the two stocks.

Get PACS Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PACS vs. The Competition

Export

Metric	PACS Group	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$7.30B	$9.65B	$6.89B	$23.42B
Dividend Yield	N/A	1.60%	2.67%	4.15%
P/E Ratio	28.70	26.62	27.07	30.65
Price / Sales	1.34	18.93	519.31	20.32
Price / Cash	28.86	15.03	26.68	18.81
Price / Book	7.36	6.14	10.62	4.74
Net Income	$191.54M	$179.69M	$3.60B	$1.07B
7 Day Performance	-0.09%	-0.98%	-1.26%	-0.46%
1 Month Performance	22.07%	4.88%	1.07%	0.67%
1 Year Performance	285.15%	13.70%	23.63%	16.45%

PACS Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PACS PACS Group	2.9432 of 5 stars	$44.77 -2.9%	$50.60 +13.0%	+273.7%	$7.30B	$5.29B	28.70	47,455
GH Guardant Health	3.419 of 5 stars	$162.14 +2.4%	$158.74 -2.1%	+218.7%	$21.50B	$982.02M	N/A	2,506	Positive News
BTSG BrightSpring Health Services	3.4918 of 5 stars	$69.91 +0.4%	$70.12 +0.3%	+253.6%	$13.79B	$12.91B	49.57	23,500
FMS Fresenius Medical Care AG & Co. KGaA	4.3517 of 5 stars	$24.24 -0.9%	$28.00 +15.5%	-9.3%	$13.02B	$22.20B	12.75	1,488	Positive News
HIMS Hims & Hers Health	2.6754 of 5 stars	$35.20 +2.4%	$30.70 -12.8%	-35.1%	$8.14B	$2.35B	N/A	2,442

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PACS) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PACS Group (PACS) Competitors

PACS vs. GH, BTSG, FMS, HIMS, and BLLN

How does PACS Group compare to Guardant Health?

Summary

How does PACS Group compare to BrightSpring Health Services?

Summary

How does PACS Group compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does PACS Group compare to Hims & Hers Health?

Summary

How does PACS Group compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PACS vs. The Competition

PACS Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PACS Group (PACS) Competitors

PACS vs. GH, BTSG, FMS, HIMS, and BLLN

How does PACS Group compare to Guardant Health?

Is PACS or GH more profitable?

Does the media prefer PACS or GH?

Which has higher earnings & valuation, PACS or GH?

Do insiders & institutionals hold more shares of PACS or GH?

Do analysts recommend PACS or GH?

Which has more risk and volatility, PACS or GH?

Summary

How does PACS Group compare to BrightSpring Health Services?

Does the media prefer PACS or BTSG?

Is PACS or BTSG more profitable?

Do analysts rate PACS or BTSG?

Which has more volatility & risk, PACS or BTSG?

Which has preferable earnings and valuation, PACS or BTSG?

Summary

How does PACS Group compare to Fresenius Medical Care AG & Co. KGaA?

Do analysts rate PACS or FMS?

Which has higher earnings and valuation, PACS or FMS?

Does the media favor PACS or FMS?

Is PACS or FMS more profitable?

Which has more risk & volatility, PACS or FMS?

Do institutionals and insiders believe in PACS or FMS?

Summary

How does PACS Group compare to Hims & Hers Health?

Which has preferable valuation & earnings, HIMS or PACS?

Which has more risk & volatility, HIMS or PACS?

Do analysts recommend HIMS or PACS?

Do institutionals & insiders hold more shares of HIMS or PACS?

Does the media favor HIMS or PACS?

Is HIMS or PACS more profitable?

Summary

How does PACS Group compare to Billiontoone?

Do analysts rate BLLN or PACS?

Which has stronger earnings and valuation, BLLN or PACS?

Does the media prefer BLLN or PACS?

Is BLLN or PACS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PACS vs. The Competition

PACS Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools